Detalles de la búsqueda
1.
Alcohol intake and endogenous sex hormones in women: Meta-analysis of cohort studies and Mendelian randomization.
Cancer
; 2024 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38824654
2.
Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP).
Br J Cancer
; 127(5): 844-854, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35618787
3.
Protein Z: A putative novel biomarker for early detection of ovarian cancer.
Int J Cancer
; 138(12): 2984-92, 2016 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26815306
4.
Cancer-associated autoantibodies to MUC1 and MUC4--a blinded casecontrol study of colorectal cancer in UK collaborative trial of ovarian cancer screening.
Int J Cancer
; 134(9): 2180-88, 2014 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24122770
5.
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study.
Lancet Oncol
; 14(12): 1226-32, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24140203
6.
DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery.
Breast Cancer Res Treat
; 120(2): 345-55, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19353266
7.
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer.
Cancer Prev Res (Phila)
; 12(6): 391-400, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30967390
8.
Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Cancer Epidemiol
; 58: 167-174, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30616086
9.
Novel risk models for early detection and screening of ovarian cancer.
Oncotarget
; 8(1): 785-797, 2017 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27903971
10.
Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.
Clin Cancer Res
; 23(19): 5912-5922, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28637689
11.
Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer.
Oncotarget
; 8(3): 3811-3825, 2017 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28002811
12.
Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
Steroids
; 110: 62-69, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27091764
13.
An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation.
BMJ Open
; 6(7): e009641, 2016 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27456325
14.
Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection.
Clin Cancer Res
; 21(3): 622-31, 2015 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24938522
15.
Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
BMJ Open
; 4(9): e005400, 2014 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25252818
16.
Identifying hopelessness in population research: a validation study of two brief measures of hopelessness.
BMJ Open
; 4(5): e005093, 2014 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-24879829
17.
A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival.
Genome Med
; 6(6): 47, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25067956
18.
Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.
Proteomics Clin Appl
; 8(11-12): 982-93, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25290619
19.
Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
Endocr Relat Cancer
; 19(2): 137-47, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22199143
20.
Corrigendum to "Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS)" [Steroids 110 (2016) 62-69].
Steroids
; 113: 113, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27519583